Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,632 Skin Cancer
clinical trials

Basal Cell Carcinoma Clinical Trial
A Study of Vismodegib With Surgery in Patients With Previously Untreated Basal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Basal Cell Carcinoma Clinical Trial
A Study of Vismodegib With Surgery in Patients With Previously Untreated Basal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
New York, NY
Click here to add this to my saved trials
Basal Cell Carcinoma Clinical Trial
A Study of Vismodegib With Surgery in Patients With Previously Untreated Basal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Basal Cell Carcinoma Clinical Trial
A Study of Vismodegib With Surgery in Patients With Previously Untreated Basal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
West Islip, NY
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
A Study of RO5185426 in Patients With Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 1/13/2016
mi
from
Dallas, TX
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
A Study of RO5185426 in Patients With Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 1/13/2016
mi
from
Detroit, MI
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
A Study of RO5185426 in Patients With Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 1/13/2016
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
A Study of RO5185426 in Patients With Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 1/13/2016
mi
from
New Haven, CT
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
A Study of RO5185426 in Patients With Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 1/13/2016
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
A Study of RO5185426 in Patients With Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 1/13/2016
mi
from
Portland, OR
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
A Study of RO5185426 in Patients With Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 1/13/2016
mi
from
Richmond, VA
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
A Study of RO5185426 in Patients With Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 1/13/2016
mi
from
San Francisco, CA
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
A Study of RO5185426 in Patients With Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 1/13/2016
mi
from
Tampa, FL
Click here to add this to my saved trials
Skin Carcinoma Clinical Trial
Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back
Status: Enrolling, Phase II
Updated: 1/13/2016
mi
from
Oakland, CA
Click here to add this to my saved trials
N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma Clinical Trial
Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma
Status: Enrolling, Phase II
Updated: 2/11/2016
mi
from
Birmingham, AL
Click here to add this to my saved trials
N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma Clinical Trial
Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma
Status: Enrolling, Phase II
Updated: 2/11/2016
mi
from
Morristown, NJ
Click here to add this to my saved trials
N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma Clinical Trial
Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma
Status: Enrolling, Phase II
Updated: 2/11/2016
mi
from
St. Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 2/16/2016
mi
from
Bartlett, TN
Click here to add this to my saved trials
Oncology Clinical Trial
An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 2/16/2016
mi
from
Bedford, TX
Click here to add this to my saved trials
Oncology Clinical Trial
An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 2/16/2016
mi
from
Brimingham, AL
Click here to add this to my saved trials
Oncology Clinical Trial
An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 2/16/2016
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Oncology Clinical Trial
An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 2/16/2016
mi
from
Detroit, MI
Click here to add this to my saved trials
Oncology Clinical Trial
An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 2/16/2016
mi
from
Eugene, OR
Click here to add this to my saved trials
Oncology Clinical Trial
An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 2/16/2016
mi
from
Germantown, TN
Click here to add this to my saved trials
Oncology Clinical Trial
An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 2/16/2016
mi
from
Lebanon, TN
Click here to add this to my saved trials
Oncology Clinical Trial
An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 2/16/2016
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 2/16/2016
mi
from
Portland, OR
Click here to add this to my saved trials
Oncology Clinical Trial
An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 2/16/2016
mi
from
San Francisco, CA
Click here to add this to my saved trials
Oncology Clinical Trial
An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 2/16/2016
mi
from
Tampa, FL
Click here to add this to my saved trials
Oncology Clinical Trial
An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 2/16/2016
mi
from
Thornton, CO
Click here to add this to my saved trials
Oncology Clinical Trial
An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 2/16/2016
mi
from
Tucson, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 2/16/2016
mi
from
Woodbury, MN
Click here to add this to my saved trials
Unresected Stage IIIb to IVM1c Melanoma Clinical Trial
Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma
Status: Enrolling, Phase III
Updated: 2/26/2016
mi
from
Dallas, TX
Click here to add this to my saved trials
Unresected Stage IIIb to IVM1c Melanoma Clinical Trial
Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma
Status: Enrolling, Phase III
Updated: 2/26/2016
mi
from
Greenville, SC
Click here to add this to my saved trials
Unresected Stage IIIb to IVM1c Melanoma Clinical Trial
Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma
Status: Enrolling, Phase III
Updated: 2/26/2016
mi
from
La Jolla, CA
Click here to add this to my saved trials
Unresected Stage IIIb to IVM1c Melanoma Clinical Trial
Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma
Status: Enrolling, Phase III
Updated: 2/26/2016
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Study Of Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutations Other Than V600E
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Morristown, NJ
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Study Of Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutations Other Than V600E
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Study Of Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutations Other Than V600E
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Study Of Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutations Other Than V600E
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
St. Louis, MO
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
A Study of Vemurafenib in Metastatic Melanoma Patients With Brain Metastases
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Aurora, CO
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
A Study of Vemurafenib in Metastatic Melanoma Patients With Brain Metastases
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Dallas, TX
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
A Study of Vemurafenib in Metastatic Melanoma Patients With Brain Metastases
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
A Study of Vemurafenib in Metastatic Melanoma Patients With Brain Metastases
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Rochester, MN
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
A Study of Vemurafenib in Metastatic Melanoma Patients With Brain Metastases
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Seattle, WA
Click here to add this to my saved trials
Malignant Melanoma, Neoplasms Clinical Trial
A Study on the Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine in Patients With BRAFV600 Mutation-Positive Metastatic Malignancies
Status: Enrolling, Phase I
Updated: 4/2/2016
mi
from
Durham, NC
Click here to add this to my saved trials
Basal Cell Carcinoma Clinical Trial
A Study of Vismodegib With Surgery in Patients With Previously Untreated Basal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Hershey, PA
Click here to add this to my saved trials
Basal Cell Carcinoma Clinical Trial
A Study of Vismodegib With Surgery in Patients With Previously Untreated Basal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Houston, TX
Click here to add this to my saved trials
Basal Cell Carcinoma Clinical Trial
A Study of Vismodegib With Surgery in Patients With Previously Untreated Basal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Madison, WI
Click here to add this to my saved trials
Basal Cell Carcinoma Clinical Trial
A Study of Vismodegib With Surgery in Patients With Previously Untreated Basal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Basal Cell Carcinoma Clinical Trial
A Study of Vismodegib With Surgery in Patients With Previously Untreated Basal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Rochester, NY
Click here to add this to my saved trials
Basal Cell Carcinoma Clinical Trial
A Study of Vismodegib With Surgery in Patients With Previously Untreated Basal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Basal Cell Carcinoma Clinical Trial
A Study of Vismodegib With Surgery in Patients With Previously Untreated Basal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
Basal Cell Carcinoma Clinical Trial
A Study of Vismodegib With Surgery in Patients With Previously Untreated Basal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
A Study of RO5185426 in Patients With Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 1/13/2016
mi
from
Nashville, TN
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
A Study of RO5185426 in Patients With Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 1/13/2016
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
A Study of RO5185426 in Patients With Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 1/13/2016
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
A Study of RO5185426 in Patients With Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 1/13/2016
mi
from
Tucson, AZ
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
A Study of DEDN6526A in Patients With Metastatic or Unresectable Melanoma
Status: Enrolling, Phase I
Updated: 2/1/2016
mi
from
Nashville, TN
Click here to add this to my saved trials
Melanoma Clinical Trial
A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor
Status: Enrolling, Phase III
Updated: 2/11/2016
mi
from
Lubbock, TX
Click here to add this to my saved trials
N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma Clinical Trial
Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma
Status: Enrolling, Phase II
Updated: 2/11/2016
mi
from
Columbus, OH
Click here to add this to my saved trials
N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma Clinical Trial
Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma
Status: Enrolling, Phase II
Updated: 2/11/2016
mi
from
Madison, WI
Click here to add this to my saved trials
N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma Clinical Trial
Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma
Status: Enrolling, Phase II
Updated: 2/11/2016
mi
from
Maywood, IL
Click here to add this to my saved trials
N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma Clinical Trial
Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma
Status: Enrolling, Phase II
Updated: 2/11/2016
mi
from
San Francisco, CA
Click here to add this to my saved trials
Oncology Clinical Trial
An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 2/16/2016
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Oncology Clinical Trial
An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 2/16/2016
mi
from
Grapevine, TX
Click here to add this to my saved trials
Oncology Clinical Trial
An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 2/16/2016
mi
from
Lakewood, CO
Click here to add this to my saved trials
Oncology Clinical Trial
An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 2/16/2016
mi
from
Louisville, KY
Click here to add this to my saved trials
Oncology Clinical Trial
An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 2/16/2016
mi
from
Maplewood, MN
Click here to add this to my saved trials
Oncology Clinical Trial
An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 2/16/2016
mi
from
Murfreesboro, TN
Click here to add this to my saved trials
Oncology Clinical Trial
An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 2/16/2016
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 2/16/2016
mi
from
Orlando, FL
Click here to add this to my saved trials
Oncology Clinical Trial
An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 2/16/2016
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Unresected Stage IIIb to IVM1c Melanoma Clinical Trial
Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma
Status: Enrolling, Phase III
Updated: 2/26/2016
mi
from
Canton, OH
Click here to add this to my saved trials
Unresected Stage IIIb to IVM1c Melanoma Clinical Trial
Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma
Status: Enrolling, Phase III
Updated: 2/26/2016
mi
from
Duarte, CA
Click here to add this to my saved trials
Unresected Stage IIIb to IVM1c Melanoma Clinical Trial
Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma
Status: Enrolling, Phase III
Updated: 2/26/2016
mi
from
Franklin, WI
Click here to add this to my saved trials
Unresected Stage IIIb to IVM1c Melanoma Clinical Trial
Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma
Status: Enrolling, Phase III
Updated: 2/26/2016
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Unresected Stage IIIb to IVM1c Melanoma Clinical Trial
Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma
Status: Enrolling, Phase III
Updated: 2/26/2016
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Unresected Stage IIIb to IVM1c Melanoma Clinical Trial
Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma
Status: Enrolling, Phase III
Updated: 2/26/2016
mi
from
Morristown, NJ
Click here to add this to my saved trials
Unresected Stage IIIb to IVM1c Melanoma Clinical Trial
Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma
Status: Enrolling, Phase III
Updated: 2/26/2016
mi
from
New York, NY
Click here to add this to my saved trials
Unresected Stage IIIb to IVM1c Melanoma Clinical Trial
Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma
Status: Enrolling, Phase III
Updated: 2/26/2016
mi
from
Omaha, NE
Click here to add this to my saved trials
Unresected Stage IIIb to IVM1c Melanoma Clinical Trial
Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma
Status: Enrolling, Phase III
Updated: 2/26/2016
mi
from
St. Louis, MO
Click here to add this to my saved trials
Unresected Stage IIIb to IVM1c Melanoma Clinical Trial
Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma
Status: Enrolling, Phase III
Updated: 2/26/2016
mi
from
Wauwatosa, WI
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Study Of Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutations Other Than V600E
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Dallas, TX
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Study Of Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutations Other Than V600E
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
La Jolla, CA
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Study Of Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutations Other Than V600E
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
New York, NY
Click here to add this to my saved trials
Malignant Melanoma, Neoplasms Clinical Trial
A Study on the Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine in Patients With BRAFV600 Mutation-Positive Metastatic Malignancies
Status: Enrolling, Phase I
Updated: 4/2/2016
mi
from
Pleasant Hill, CA
Click here to add this to my saved trials
Basal Cell Carcinoma Clinical Trial
A Study of Vismodegib With Surgery in Patients With Previously Untreated Basal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Basal Cell Carcinoma Clinical Trial
A Study of Vismodegib With Surgery in Patients With Previously Untreated Basal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Portland, OR
Click here to add this to my saved trials
Basal Cell Carcinoma Clinical Trial
A Study of Vismodegib With Surgery in Patients With Previously Untreated Basal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
San Francisco, CA
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
A Study of RO5185426 in Patients With Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 1/13/2016
mi
from
Atlanta, GA
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
A Study of RO5185426 in Patients With Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 1/13/2016
mi
from
Aurora, CO
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
A Study of RO5185426 in Patients With Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 1/13/2016
mi
from
Columbia, SC
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
A Study of RO5185426 in Patients With Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 1/13/2016
mi
from
Seattle, WA
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
A Study of DEDN6526A in Patients With Metastatic or Unresectable Melanoma
Status: Enrolling, Phase I
Updated: 2/1/2016
mi
from
Detroit, MI
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
A Study of DEDN6526A in Patients With Metastatic or Unresectable Melanoma
Status: Enrolling, Phase I
Updated: 2/1/2016
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Melanoma Clinical Trial
A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor
Status: Enrolling, Phase III
Updated: 2/11/2016
mi
from
Ciudad Autonoma de Buenos Aires,
Click here to add this to my saved trials
N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma Clinical Trial
Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma
Status: Enrolling, Phase II
Updated: 2/11/2016
mi
from
Boston, MA
Click here to add this to my saved trials
N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma Clinical Trial
Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma
Status: Enrolling, Phase II
Updated: 2/11/2016
mi
from
Orlando, FL
Click here to add this to my saved trials
Oncology Clinical Trial
An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 2/16/2016
mi
from
Adelaide,
Click here to add this to my saved trials
1 58 59 60 61 62 63 64 65 66